N-terminal proBNP--marker of cardiac dysfunction, fluid overload, or malnutrition in hemodialysis patients? - Wikidata - awgldk - TriplyDB

N-terminal proBNP--marker of cardiac dysfunction, fluid overload, or malnutrition in hemodialysis patients?

N-terminal proBNP--marker of cardiac dysfunction, fluid overload, or malnutrition in hemodialysis patients?

http://www.wikidata.org/entity/Q33888435

about

Techniques for the assessment of volume status in patients with end stage renal disease.Fluid overload in hemodialysis patients: a cross-sectional study to determine its association with cardiac biomarkers and nutritional status.B-type natriuretic peptide and prognosis of end-stage renal disease: a meta-analysis.N-terminal pro-B-type natriuretic peptide variability in stable dialysis patients The role of natriuretic peptides in volume assessment and mortality prediction in Haemodialysis patients Comparison of volume status in asymptomatic haemodialysis and peritoneal dialysis outpatients.Comparison of hydration and nutritional status between young and elderly hemodialysis patients through bioimpedance analysis.N-Terminal Pro-B-Type Natriuretic Peptide as a Biomarker for Loss of Muscle Mass in Prevalent Hemodialysis Patients.Can non-invasive measurements aid clinical assessment of volume in patients with cirrhosis?Is overhydration in peritoneal dialysis patients associated with cardiac mortality that might be reversible?Diagnostic and prognostic values of B-type natriuretic peptides (BNP) and N-terminal fragment brain natriuretic peptides (NT-pro-BNP).B-type natriuretic peptide is not a volume marker among patients on hemodialysis Renocardiovascular Biomarkers: from the Perspective of Managing Chronic Kidney Disease and Cardiovascular Disease.Sudden cardiac death in patients with chronic kidney disease: prevention is the sine qua non.Clinical utility of natriuretic peptides in dialysis patients.Hemodialysis for infants, children, and adolescents.Incremental haemodialysis.Screening for muscle loss in patients established on peritoneal dialysis using bioimpedance.Brain Natriuretic Peptide and Body Fluid Composition in Patients with Chronic Kidney Disease: A Cross-Sectional Study to Evaluate the Relationship between Volume Overload and Malnutrition.Differences in prescribed Kt/V and delivered haemodialysis dose--why obesity makes a difference to survival for haemodialysis patients when using a 'one size fits all' Kt/V target.Changes in N-terminal pro-brain natriuretic peptide correlate with fluid volume changes assessed by bioimpedance in peritoneal dialysis patients.Associations between bioelectrical impedance parameters and cardiovascular events in chronic dialysis patients.Total Body Water Dynamics Estimated with Bioelectrical Impedance Vector Analysis and B-Type Natriuretic Peptide After Exposure to Hypobaric Hypoxia: A Field Study.Peritoneal Protein Losses Depend on More Than Just Peritoneal Dialysis Modality and Peritoneal Membrane Transporter Status.Evaluation of volume overload by bioelectrical impedance analysis, NT-proBNP and inferior vena cava diameter in patients with stage 3&4 and 5 chronic kidney disease.Diagnostic value of B-type natriuretic peptide for estimating left atrial size and its usefulness for predicting all-cause mortality and cardiovascular events among chronic haemodialysis patients.Body Composition and Inflammation in Hemodialysis Patients.Assessing the hydration status of children with chronic kidney disease and on dialysis: a comparison of techniques.Investigation of optimum N-terminal probrain natriuretic peptide level in patients on maintained hemodialysis.Are levels of brain natriuretic peptides useful to determine volume status in dialysis patients?N-terminal-pro-B-type-natriuretic peptide associated with 2-year mortality from both cardiovascular and non-cardiovascular origins in prevalent chronic hemodialysis patients.Does Peritoneal Protein Transport Increase with Peritoneal Dialysis Therapy Duration and Lead to Extracellular Water Overload in Peritoneal Dialysis Patients?Association between OH/ECW and echocardiographic parameters in CKD5 patients not undergoing dialysis.Dialysis and Patient Factors Which Determine Convective Volume Exchange in Patients Treated by Postdilution Online Hemodiafiltration.The interaction between N-terminal pro-brain natriuretic peptide and fluid status in adverse clinical outcomes of late stages of chronic kidney disease

P2860

Q30458665-A020657F-B68A-46B1-8A98-D8CC93C31443 Q34448843-1B44FEF5-F283-41D0-B54E-FBFF96955501 Q35043782-354418F8-F656-40FC-B4BC-102356ED2A95 Q35278624-AEB928A7-86A6-4CC2-85DD-50BFE38F2E93 Q35880977-5BC7C17E-D2EB-43DD-8B5D-5F957BEBB4B7 Q35953291-0A95604B-04FA-4CEC-8A8D-3DE3FD983B58 Q35970671-426AA057-2179-42CE-91DA-50A8CADE41AD Q36199888-6699494F-B8EB-472B-BB1C-7C5C11AEFBCF Q37157856-AEF2FC19-703A-4BF7-9053-2C51838BAAD5 Q37231805-AF258179-9CC8-45F7-9849-66131D7F0869 Q37253670-76C1F1C2-4664-45EC-A0E0-237352BDA9C3 Q37349694-1A1DBCFE-B14D-47ED-AE80-DADA12B5C058 Q37681556-63E7E6F2-3256-41B6-88F1-ABCBC2C6EAD2 Q37892314-6E800619-9BFC-4E9B-8836-4E0456D54BC1 Q38011232-D6209CEE-501F-4140-88BE-F8C678439282 Q38203967-5B305C5A-2C53-42E3-9B6D-F65A1A1A8F8C Q38514179-9AC5979D-B233-4BD8-9B48-B98082DD15EF Q39249156-9AB4A3AD-379F-4E03-B200-860BE4058AF2 Q41073009-5D1869F0-EBDD-4066-978A-B89524C45706 Q44298753-0759E368-4C57-4BA1-8D3A-54F3D2B65C9B Q44569543-8B60BCAA-6F86-4BFB-BAD1-74A9D57ADC30 Q46517564-597DE731-9555-45D6-9FB0-277A1CB6B7FB Q47153207-CB0DB933-88FD-4655-94D8-3806270F7453 Q47190973-F0A2A305-B8CD-4CD7-8CA0-81C8DF925000 Q47222213-207EC7E6-8F11-4C97-B007-DEC347084FBF Q47441254-CE11A88A-A101-43CE-A915-F89B69393A43 Q47755940-25126733-CA15-4101-A0A9-1B1665A142F8 Q47970134-A63AD412-43C1-4978-88F2-EF2E7416FEA3 Q48305504-61F809E3-BE6B-4AC2-9B9B-07F8513037C7 Q48944257-C5E820A0-01DD-4010-8610-42C773769CD0 Q49853451-3C1664C1-043E-49B9-B46D-CFCDB3922224 Q50943813-80E341C2-5C50-4E9C-A62E-63D46229F12C Q52598777-CE75252F-1BB9-4EDF-B2F5-521152BDD159 Q53091077-F4309137-2028-474C-A35F-73DB614A4B97 Q58722934-753CB92D-1006-49A3-BC1A-170E87ACD7E5

P2860

N-terminal proBNP--marker of cardiac dysfunction, fluid overload, or malnutrition in hemodialysis patients?

http://www.wikidata.org/entity/Q33888435

description

2010 nî lūn-bûn

@nan

2010 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

N-terminal proBNP--marker of c ...... tion in hemodialysis patients?

@ast

N-terminal proBNP--marker of c ...... tion in hemodialysis patients?

@en

type

label

N-terminal proBNP--marker of c ...... tion in hemodialysis patients?

@ast

N-terminal proBNP--marker of c ...... tion in hemodialysis patients?

@en

prefLabel

N-terminal proBNP--marker of c ...... tion in hemodialysis patients?

@ast

N-terminal proBNP--marker of c ...... tion in hemodialysis patients?

@en

P1433

Q33888435-9C23622C-C326-4B69-AE1E-927478D9FCCE

P1476

Q33888435-57AB30A2-0FD1-4731-B6E7-440D0D5EAB3F

P2093

Q33888435-D761F573-EE30-4F22-BE37-66D8410C0594

Q33888435-EA31DF8A-9950-4C53-90EA-FC9F95BE6340

Q33888435-EC97787F-D698-4EDB-9B95-CF3720F82046

P2860

Q33888435-03304553-1AF8-4F32-98BF-3D259C290DEA

Q33888435-0FA1B3D6-0B4B-481F-9D12-3A2DE07F67E5

Q33888435-28286EC5-5026-4EA0-BC86-10F0590730F9

Q33888435-2D44E9C3-7629-4FF1-970B-236B7E4BAEC9

Q33888435-3ABD4E52-2E8F-4823-83F8-4FAEB3EC2334

Q33888435-48ADEF99-01D3-4271-80C9-EA1C3BCBCE19

Q33888435-67A2A97E-EDC6-47FC-B1B4-55BD2270B637

Q33888435-9EC6C316-DB4E-45E6-A436-17031EC8B66C

Q33888435-BDA32990-9C87-475D-9E9E-7D110FA5B4A5

Q33888435-C9610B49-2F81-436D-9685-B973A62B8943

P304

Q33888435-5D6C4479-9010-4268-BEE5-EDEC4293C235

P31

Q33888435-C3944DB6-AE0E-493D-833E-8D4099985F7F

P356

Q33888435-15E24147-8B77-4FE6-A7BA-CDF476A5ADFF

P433

Q33888435-C55ED85A-74BA-4095-A20C-00FAC274ABBC

P478

Q33888435-45466979-D1C1-4DEB-B018-BC96D6E91A21

P577

Q33888435-974CCCB1-D8CD-49AB-9F5E-073F66A8D287

P698

Q33888435-6CC4A8B7-EE23-4B76-A890-28DB42D45214

P921

Q33888435-DB29B6BE-7D39-4435-8F59-CDCD28723AA6

P932

Q33888435-E9020E07-FB73-4B81-96F8-552FE9C86ED6

P356

P1433

Clinical Journal of the American Society of Nephrology

P1476

N-terminal proBNP--marker of c ...... tion in hemodialysis patients?

@en

P2093

Andrew Davenport

http://www.w3.org/2001/XMLSchema#string

Jennifer Pinney

http://www.w3.org/2001/XMLSchema#string

John Booth

http://www.w3.org/2001/XMLSchema#string

P2860

The use of B-type natriuretic peptide to assess volume status in patients with end-stage renal disease.

Haemodynamic consequences of changing bicarbonate and calcium concentrations in haemodialysis fluids.

Hydration status does not influence peritoneal equilibration test ultrafiltration volumes.

Cardiovascular disease and mortality in ESRD.

Fluid balance in patients with chronic renal failure assessed with N-terminal proatrial natriuretic peptide, atrial natriuretic peptide and ultrasonography.

NT-proBNP, fluid volume overload and dialysis modality are independent predictors of mortality in ESRD patients.

N-terminal pro brain natriuretic peptide predicts mortality in patients with end-stage renal disease in hemodialysis.

The prognostic role of brain natriuretic peptides in hemodialysis patients.

Inflammation, overhydration and cardiac biomarkers in haemodialysis patients: a longitudinal study.

Association between serum n-terminal pro-brain natriuretic peptide concentration and left ventricular dysfunction and extracellular water in continuous ambulatory peritoneal dialysis patients.

P304

1036-1040

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2215/CJN.09001209

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2010-05-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20507952

http://www.w3.org/2001/XMLSchema#string

P921

P932

2879314

http://www.w3.org/2001/XMLSchema#string